Strength of Evidence for Perioperative Use of Statins to Reduce Cardiovascular Risk: Systematic Review of Controlled Studies.
From: Division of General Internal Medicine, University of Alberta, 8440 112 Street, Edmonton, AB, Canada T6G 2R7.
BMJ (Clinical research ed.)
- Publish Date: Dec 2006
- ISSN: 1468-5833
- Volume: 333
- Issue: 7579
- Pages: 1149
- Medium: Internet
- Language: English
- Citation (JAMA): Kapoor Anmol S, Kanji Hussein, Buckingham Jeanette, et al. Strength of Evidence for Perioperative Use of Statins to Reduce Cardiovascular Risk: Systematic Review of Controlled Studies.. BMJ Dec 2006;333:1149
Abstract
OBJECTIVE: To determine the strength of evidence underlying recommendations for use of statins during the perioperative period to reduce the risk of cardiovascular events. DESIGN: Systematic review of studies with concurrent control groups. DATA SOURCES: Four electronic databases, the references of identified studies, international experts on perioperative medicine, and the authors of the primary studies. Review methods Two reviewers independently extracted data from studies that reported acute coronary syndromes or mortality in patients receiving or not receiving statins during the perioperative period. MAIN OUTCOME MEASURE: Random effects summary odds ratios for death or acute coronary syndrome during the perioperative period. RESULTS: 18 studies — two randomised trials (n=177), 15 cohort studies (n=799,632), and one case-control study (n=480) — assessed whether statins provide perioperative cardiovascular protection; 12 studies enrolled patients undergoing non-cardiac vascular surgery, four enrolled patients undergoing coronary bypass surgery, and two enrolled patients undergoing various surgical procedures. In the randomised trials the summary odds ratio for death or acute coronary syndrome during the perioperative period with statin use was 0.26 (95% confidence interval 0.07 to 0.99) and the summary odds ratio in the cohort studies was 0.70 (0.57 to 0.87). Although the pooled cohort data provided a statistically significant result, statins were not randomly allocated, results in retrospective studies were larger (odds ratio 0.65, 0.50 to 0.84) than those in the prospective cohorts (0.91, 0.65 to 1.27), and dose, duration, and safety of statin use was not reported. CONCLUSION: The evidence base for routine administration of statins to reduce perioperative cardiovascular risk is inadequate.
Mesh Headings (Keywords): Case-Control Studies, Coronary Disease, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Intraoperative Complications, Preoperative Care, Randomized Controlled Trials as Topic, Risk Factors, Survival Analysis
Check for Full Text / PubMed Unique Identifier (PMID): 17088313
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.